Editing
Coronavirus Analysis
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[https://github.com/galaxyproject/SARS-CoV-2 https://github.com/galaxyproject/SARS-CoV-2] Haplotype analyses were conducted on the alignment of coding regions using DnaSP. Evolutionary analysis of haplotypes used NETWORK. Population size changes were estimated using both DnaSP and Arlequin genome sequences were aligned using MAFFT,18 then the alignment was manually checked using Geneious (Biomatters, New Zealand). The alignment was then imported into DnaSP19 for haplotype analyses. Population size changes were estimated based on a constant population size hypothesis using DnaSP, in combination with neutrality tests (Tajima’s D and Fu’s Fs). We also used Arlequin20 to test the sudden population expansion hypothesis and to calculate the expansion parameter tau (τ) if sudden population expansion is not rejected. We used the formula t=τ/2u to estimate the time since expansion (in days). In the formula, u is the cumulative substitution rate per year (for the genome sequence, so we used the formula u = μk to calculate it, where μ is the substitution rate per site per year, and k is the genome sequence length (29,358 bp for the CDS matrix). In this study, the substitution rate was set as 0·92×10 3 (95% CI, 0·33×10 3 1·46×10 3) substitution/site/year based on the most recent estimation for SARS CoV 2.21 A median joining network of haplotypes was generated by the NETWORK program22 with bat RaTG13 CoV as the outgroup. Phylogenomic analyses of haplotypes were performed using IQ TREE23. We conducted likelihood mapping and SH like approximate likelihood ratio tests to assess the phylogenetic information and branch supports,
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages